VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 62 filers reported holding VERRICA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $86,060 | – | 13,240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 62,882 | $512,000 | 1.42% |
| Diag Capital Management, LP | 114,947 | $937,000 | 1.07% |
| Perceptive Advisors | 3,410,412 | $27,794,000 | 1.06% |
| Fosun International Ltd | 794,279 | $6,473,000 | 0.39% |
| Orbimed Advisors | 1,479,733 | $12,060,000 | 0.22% |
| PURA VIDA INVESTMENTS, LLC | 63,916 | $521,000 | 0.10% |
| SPHERA FUNDS MANAGEMENT LTD. | 97,000 | $791,000 | 0.09% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 327,420 | $2,668,000 | 0.05% |
| Capital Investment Advisory Services, LLC | 12,400 | $101,000 | 0.04% |
| CONNING INC. | 129,013 | $1,051,000 | 0.04% |